H.RES. 1285In Committee
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Key facts
Introduced: May 14, 2026
Chamber: House
Cosponsors: 12
Congress: 119th
Latest action · May 14, 2026
Referred to the House Committee on Energy and Commerce.
Timeline
- May 14, 2026Referred to the House Committee on Energy and Commerce.
- May 14, 2026Submitted in House
Cosponsors
- Rep. Pressley, Ayanna [D-MA-7] D-MA
- Rep. McClellan, Jennifer L. [D-VA-4] D-VA
- Rep. Clark, Katherine M. [D-MA-5] D-MA
- Rep. Bell, Wesley [D-MO-1] D-MO
- Rep. Tonko, Paul [D-NY-20] D-NY
- Rep. García, Jesús G. "Chuy" [D-IL-4] D-IL
- Rep. Velázquez, Nydia M. [D-NY-7] D-NY
- Rep. Moulton, Seth [D-MA-6] D-MA
- Rep. Pettersen, Brittany [D-CO-7] D-CO
- Del. Norton, Eleanor Holmes [D-DC-At Large] D-DC
- Rep. Balint, Becca [D-VT-At Large] D-VT
- Rep. Dexter, Maxine [D-OR-3] D-OR
View official record on Congress.gov →
Make your voice heard
Contact your representatives about this bill in under 2 minutes.
📬 Contact Your Reps →